2023-03-01 07160040 2024-02-29 07160040 2023-03-01 2024-02-29 07160040 2023-02-28 07160040 2022-03-01 2023-02-28 07160040 uk-core:WithinOneYear 2023-02-28 07160040 uk-core:WithinOneYear 2024-02-29 07160040 uk-core:AfterOneYear 2023-02-28 07160040 uk-core:AfterOneYear 2024-02-29 07160040 uk-core:ShareCapital 2024-02-29 07160040 uk-core:ShareCapital 2023-02-28 07160040 uk-core:RetainedEarningsAccumulatedLosses 2024-02-29 07160040 uk-core:RetainedEarningsAccumulatedLosses 2023-02-28 07160040 uk-bus:Director1 2023-03-01 2024-02-29 07160040 uk-core:ToolsEquipment 2023-02-28 07160040 uk-core:FurnitureFittings 2023-02-28 07160040 uk-core:PlantMachinery 2023-02-28 07160040 uk-core:ToolsEquipment 2023-03-01 2024-02-29 07160040 uk-core:FurnitureFittings 2023-03-01 2024-02-29 07160040 uk-core:PlantMachinery 2023-03-01 2024-02-29 07160040 uk-core:PlantMachinery 2024-02-29 07160040 uk-core:FurnitureFittings 2024-02-29 07160040 uk-core:ToolsEquipment 2024-02-29 iso4217:GBP xbrli:pure 07160040 uk-bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 07160040 uk-bus:FRS102 2023-03-01 2024-02-29 07160040 uk-bus:FilletedAccounts 2023-03-01 2024-02-29 07160040 uk-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29
RADMED Limited
Registered Number:07160040
For the year ended 29 February 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 29 February 2024
RADMED Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
07160040
As at 29 February 2024
RADMED Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
10,178
8,732
2
10,178
8,732
Current assets
Trade and other receivables
114,912
171,771
3
131,169
Cash and cash equivalents
66,764
238,535
246,081
Trade and other payables: amounts falling due within one
year
(12,721)
(25,205)
4
233,360
213,330
Net current assets
Total assets less current liabilities
223,508
242,092
Trade and other payables: amounts falling due after more
than one year
-
(16,399)
5
207,109
Net assets
242,092
Capital and reserves
Called up share capital
100
100
Retained earnings
207,009
241,992
207,109
242,092
Shareholders' funds
For the year ended 29 February 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mr Zoltan Nagy Director
These financial statements were approved and authorised for issue by the Board on 27 November 2024 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 29 February 2024
RADMED Limited
Notes to the Financial Statements
Statutory Information
RADMED Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 07160040.
Registered address:
5 Chigwell Road
London
E18 1LR
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Revenue recognition
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2. Property, plant and equipment
Total
Computer
equipment
Fixtures and
fittings
Plant and
machinery
£
£
£
£
Cost or
valuation
At 01 March 2023
28,076
20,189
7,887
-
4,666
968
3,180
518
Additions
At 29 February 2024
518
11,067
21,157
32,742
Provision for depreciation and impairment
At 01 March 2023
19,344
14,344
5,000
-
Charge for year
3,220
1,703
1,517
-
At 29 February 2024
22,564
16,047
6,517
-
At 29 February 2024
Net book value
518
4,550
5,110
10,178
At 28 February 2023
-
2,887
5,845
8,732
3. Trade and other receivables
2023
2024
£
£
Other debtors
171,771
114,912
2 of 3
5
For the year ended 29 February 2024
RADMED Limited
Notes to the Financial Statements Continued
4. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Trade creditors
(1)
-
Taxation and social security
24,858
12,427
Other creditors
348
294
25,205
12,721
5. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft (secured)
16,399
-
6. Average number of persons employed
During the year the average number of employees was 1 (2023 : 1)
3 of 3